Immediate Impact

6 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
1 intermediate paper

Works of Max Schreuer being referenced

Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial
2017
Characterization of thein vivoimmune network of IDO, tryptophan metabolism, PD-L1, andCTLA-4in circulating immune cells in melanoma
2015

Author Peers

Author Last Decade Papers Cites
Max Schreuer 515 253 217 20 712
Jan Anderl 303 346 160 18 786
Dishui Gu 171 353 121 13 575
Isabelle Soubeyran 348 358 153 25 738
Shan-Shan Jiang 373 300 361 18 787
Arif Y. Shaikh 289 269 220 15 679
Kousik Kesh 379 454 185 21 773
Oliver Umland 232 276 231 22 700
Qianfei Zhang 308 193 309 15 692
Brian Labadie 366 271 326 23 724
Nikita Mani 462 144 234 23 661

All Works

Loading papers...

Rankless by CCL
2026